GALLI, GIULIA
GALLI, GIULIA
Dipartimento di Oncologia ed Emato-Oncologia
THE EUDRACT 2017-004494-13 TRIAL ON THYMIC EPITHELIAL TUMORS: THE PARADIGM OF A COMPREHENSIVE STUDY FOR A RARE DISEASE
2022 G. Galli
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
2022 F. Giugliano, P.A. Zucali, G. Galli, Z. Ballatore, C. Corti, P.T. Aliaga, J. Uliano, G. Vivanet, G. Curigliano, F. Conforti, P. Queirolo, R. Berardi, S. Manglaviti, G. Apollonio, M. Perrino, F. Borea, F. D'Antonio, M.C. Garassino, T. De Pas
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer
2022 G. Galli, P.A. Corsetto, C. Proto, G. Lo Russo, M. Ganzinelli, E. Rulli, L. Legramandi, D. Morelli, R. Ferrara, A. Prelaj, D. Signorelli, A. De Toma, M. Brambilla, M. Occhipinti, S. Manglaviti, M. Boeri, A. Martinetti, A. Vingiani, M.P. Colombo, A.M. Rizzo, V. Torri, F. de Braud, S. Sangaletti, A. Sica, M.C. Garassino
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences
2021 S. Petrocchi, R. Janssens, S. Oliveri, R. Arnou, I. Durosini, P. Guiddi, E. Louis, M. Vandevelde, K. Nackaerts, M.Y. Smith, G. Galli, F. de Marinis, L. Gianoncelli, G. Pravettoni, I. Huys
Patient preferences for lung cancer treatments : A study protocol for a preference survey using discrete choice experiment and swing weighting
2021 D. Monzani, S. Petrocchi, S. Oliveri, J. Veldwijk, R. Janssens, L. Bailo, M.Y. Smith, I. Smith, E. Schoefs, K. Nackaerts, M. Vandevelde, E. Louis, H. Decaluwé, P. De Leyn, H. Declerck, E.G. Katz, F. Petrella, M. Casiraghi, I. Durosini, G. Galli, M.C. Garassino, G.A. de Wit, G. Pravettoni, I. Huys
Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an Italian reference Center
2020 G. Galli, A. Trama, L. Abate-Daga, M. Brambilla, M. Chiara Garassino, A. Fabbri
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
2019 C. Proto, R. Ferrara, D. Signorelli, G. Lo Russo, G. Galli, M. Imbimbo, A. Prelaj, N. Zilembo, M. Ganzinelli, L. Pallavicini, I. De Simone, M. Colombo, A. Sicad, V. Torri, M. Garassino
Association between Antibiotic-Immunotherapy Exposure Ratio and outcome in metastatic Non Small Cell Lung Cancer
2019 G. Galli, T. Triulzi, C. Proto, D. Signorelli, M. Imbimbo, M. Poggi, G. Fucà, M. Ganzinelli, M. Vitali, D. Palmieri, A. Tessari, F. de Braud, M. Garassino, M. Colombo, G. Lo Russo
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study
2019 G. Fucà, L. Mariani, S. Lo Vullo, G. Galli, R. Berardi, M. Di Nicola, C. Vernieri, D. Morelli, K. Dotti, I. Fiordoliva, S. Rinaldi, C. Gavazzi, F. Pietrantonio, M. Platania, F. de Braud
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis
2019 G. Galli, S. Cavalieri, L. Di Guardo, C. Cimminiello, F. Nichetti, F. Corti, M. Garcia, B. Pappalardi, C. Fallai, F. de Braud, M. Platania, M. Del Vecchio
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
2019 G. Galli, A. De Toma, F. Pagani, G. Randon, B. Trevisan, A. Prelaj, R. Ferrara, C. Proto, D. Signorelli, M. Ganzinelli, N. Zilembo, F. de Braud, M. Garassino, G. Lo Russo
Metformin plus /- cyclic fasting mimicking diet in combination with platinum-pemetrexed chemotherapy for advanced LKB1 inactive lung adenocarcinoma : The FAME trial
2019 G. Galli, D. Signorelli, C. Vernieri, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, C. Gavazzi, A.M. Rizzo, P. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer
2019 G. Galli, C. Proto, M. Cossa, B. Valeri, S. Sdao, D. Signorelli, M. Imbimbo, F. de Braud, M. Garassino, G. Lo Russo
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2019 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, R. Ferrara, N. Zilembo, M. Ganzinelli, A. Sica, V. Torri, M. Colombo, C. Vernieri, A. Balsari, F. de Braud, M. Garassino, D. Signorelli
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study
2019 G. Mariani, G. Galli, S. Cavalieri, P. Valagussa, G. Bianchi, G. Capri, S. Cresta, L. Ferrari, S. Damian, M. Duca, F. de Braud, A. Moliterni
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma : the FAME Trial
2019 C. Vernieri, D. Signorelli, G. Galli, M. Ganzinelli, M. Moro, A. Fabbri, E. Tamborini, M. Marabese, E. Caiola, M. Broggini, L. Hollander, R. Gallucci, G. Vandoni, C. Gavazzi, T. Triulzi, M.P. Colombo, A.M. Rizzo, P.A. Corsetto, G. Pruneri, F. de Braud, G. Sozzi, V. Torri, M.C. Garassino
Clinical implications for pro-GRP in small cell lung cancer. A single center experience
2018 S. Cavalieri, D. Morelli, A. Martinetti, G. Galli, F. Nichetti, F.G.M. DE BRAUD, M. Platania
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : results from Neo-ALTTO
2018 S. Di Cosimo, C. Campbell, H.A. Azim, G. Galli, G. Bregni, G. Curigliano, C. Criscitiello, M. Izquierdo, L. de la Pena, D. Fumagalli, L. Fein, J. Vinholes, W.M.J. Ng, M. Colleoni, A. Ferro, B.J. Naume, A. Patel, J. Huober, M.J. Piccart-Gebhart, J. Baselga, E. de Azambuja
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
2018 G. Fucà, G. Galli, M. Poggi, G. Lo Russo, C. Proto, M. Imbimbo, M. Vitali, M. Ganzinelli, C. Lanti, G. Molino, F. Stangoni, N. Zilembo, F. de Braud, M. Garassino, D. Signorelli
Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors : a case series and literature review
2018 G. Galli, G. Corrao, M. Imbimbo, C. Proto, D. Signorelli, M. Ganzinelli, N. Zilembo, M. Vitali, F. de Braud, M.C. Garassino, G. Lo Russo